UCB’s goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With a promising pipeline, our focus is on neurological and immunological diseases to
provide new treatments for specialists and their patients.
At UCB, everything we do starts with a simple question: “how can we create more value for people living with severe diseases?”.
UCB has made a major contribution to improving epilepsy care and continues to work on addressing key unmet needs in epilepsy, notably drug-resistant epilepsy and disease modification.
We contribute to cutting-edge research leading to the identification of novel AED targets, and validation of mechanisms that will pave the way for future therapeutic solutions for epilepsy patients.
Check out our Community Resources!
We are proud of our sponsors and appreciate their continued support